Literature DB >> 17015695

Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.

Aixin Yu1, Thomas R Malek.   

Abstract

The development and maintenance of T regulatory (Treg) cells critically depend on IL-2. This requirement for IL-2 might be due to specificity associated with IL-2R signal transduction or because IL-2 was uniquely present in the niche in which Treg cells reside. To address this issue, we examined the capacity of IL-7R-dependent signaling to support Treg cell production and prevent autoimmunity in IL-2Rbeta(-/-) mice. Expression of transgenic wild-type IL-7R or a chimeric receptor that consisted of the extracytoplasmic domain of the IL-7R alpha-chain and the cytoplasmic domain of IL-2R beta-chain in IL-2Rbeta(-/-) mice did not prevent autoimmunity. Importantly, expression of a chimeric receptor that consisted of the extracytoplasmic domain of the IL-2R beta-chain and the cytoplasmic domain of IL-7R alpha-chain in IL-2Rbeta(-/-) mice led to Treg cells production in the thymus and periphery and prevented autoimmunity. Signaling through the IL-2R or chimeric IL-2Rbeta/IL-7Ralpha in vivo or the culture of thymocytes from IL-2Rbeta(-/-) mice with IL-7 led to up-regulation of Foxp3 and CD25 on Treg cells. These findings indicate that IL-7R signal transduction is competent to promote Treg cell production, but this signaling requires triggering through IL-2 by binding to the extracytoplasmic portion of the IL-2R via this chimeric receptor. Thus, a major factor controlling the nonredundant activity of the IL-2R is selective compartmentalization of IL-2-producing cells with Treg cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015695     DOI: 10.4049/jimmunol.177.8.5115

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism.

Authors:  Alicia Benson; Sean Murray; Prashanthi Divakar; Nikolay Burnaevskiy; Reed Pifer; James Forman; Felix Yarovinsky
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

Review 2.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

3.  PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.

Authors:  Takeru Asano; Yusuke Meguri; Takanori Yoshioka; Yuriko Kishi; Miki Iwamoto; Makoto Nakamura; Yasuhisa Sando; Hideo Yagita; John Koreth; Haesook T Kim; Edwin P Alyea; Philippe Armand; Corey S Cutler; Vincent T Ho; Joseph H Antin; Robert J Soiffer; Yoshinobu Maeda; Mitsune Tanimoto; Jerome Ritz; Ken-Ichi Matsuoka
Journal:  Blood       Date:  2017-02-01       Impact factor: 22.113

4.  Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.

Authors:  Irina V Pinchuk; Ellen J Beswick; Jamal I Saada; Gushyalatha Boya; David Schmitt; Gottumukkala S Raju; Julia Brenmoehl; Gerhard Rogler; Victor E Reyes; Don W Powell
Journal:  Gastroenterology       Date:  2011-03-02       Impact factor: 22.682

Review 5.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

6.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

7.  A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.

Authors:  Allison L Bayer; Joon Youb Lee; Anabel de la Barrera; Charles D Surh; Thomas R Malek
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.

Authors:  Mark S Wilson; John T Pesce; Thirumalai R Ramalingam; Robert W Thompson; Allen Cheever; Thomas A Wynn
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Authors:  Aixin Yu; Linjian Zhu; Norman H Altman; Thomas R Malek
Journal:  Immunity       Date:  2009-01-29       Impact factor: 31.745

10.  Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Authors:  S Alice Long; Karen Cerosaletti; Paul L Bollyky; Megan Tatum; Heather Shilling; Sheng Zhang; Zhong-Yin Zhang; Catherine Pihoker; Srinath Sanda; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.